TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ALVO

Alvotech

Healthcare · Drug Manufacturers - Specialty & Generic

6.20$ +7.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Alvotech (ALVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 586 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALVO
Line item 2019 2020 2021 2022 2023 2024 2025
32 67 37 83 91 490 586
– 0.0 0.0 64 161 185 236
32 67 37 19 -69 304 351
96 148 191 181 211 171 184
49 59 84 187 73 61 91
93 204 272 365 285 235 273
-61 -138 -235 -346 -355 70 78
96 97 113 91 135 158 149
-209 -292 -149 -552 -651 -218 136
0.5 -122 -48 -38 -99 14 108
-210 -170 -102 -514 -552 -232 28
-99 -178 -18 -440 -494 -32 323

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?